» Articles » PMID: 38106925

Adherence to Complication Reporting for Randomized Controlled Trials Contained in Clinical Practice Guidelines for the Management of Carpal Tunnel Syndrome

Overview
Date 2023 Dec 18
PMID 38106925
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Randomized controlled trials (RCTs) are frequently used in creating recommendations contained within clinical practice guidelines (CPGs). However, investigations outside of hand surgery have reported that RCTs within CPGs infrequently report complications and harms-related data. Our purpose was to assess adherence to complication reporting and harms-related outcomes contained in the Consolidated Standards for Reporting (CONSORT) Extension of Harms and Standards for Reporting of Diagnostic Accuracy Studies (STARD) reporting checklists for RCTs within the American Academy of Orthopaedic Surgery (AAOS) CPGs for carpal tunnel syndrome (CTS).

Methods: We identified all RCTs within the AAOS CTS CPGs. All therapeutic RCTs and diagnostic studies were included. We used the CONSORT Harms Checklist criteria to assess adherence to the reporting of adverse events for therapeutic RCTs and the STARD criteria to assess the diagnostic accuracy of the articles. We defined adequate compliance as adherence to ≥50% of the checklist items.

Results: We identified 82 therapeutic RCTs and 90 diagnostic accuracy articles within the AAOS CTS CPG. For therapeutic RCTs, we found that the average compliance with the published checklists was 19%. For diagnostic studies, the average compliance with checklists was found to be 55%. Eleven therapeutic RCTs (13%) and 60 diagnostic studies (67%) were determined to have adequate compliance for the CONSORT and STARD checklists, respectively.

Conclusions: Randomized controlled trials in the AAOS CPGs for CTS have low compliance with the CONSORT Extension for Harms Checklist. Although the overall adherence to the items published in the STARD statement for diagnostic accuracy evaluation remains higher, future efforts should be made to improve the adherence rates to both checklists.

Clinical Relevance: Improved standardization of complication reporting may aid in comparing outcomes across multiple clinical investigations of upper-extremity procedures.

References
1.
Turner L, Shamseer L, Altman D, Schulz K, Moher D . Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev. 2012; 1:60. PMC: 3564748. DOI: 10.1186/2046-4053-1-60. View

2.
Golder S, Loke Y, Wright K, Norman G . Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review. PLoS Med. 2016; 13(9):e1002127. PMC: 5029817. DOI: 10.1371/journal.pmed.1002127. View

3.
Anderson J, Howard C, Hardin J, Phelps C, Hanson C, Anderson R . Harms-related data are poorly reported among randomized controlled trials underpinning the American Academy of Orthopaedic Surgeons clinical practice guideline recommendations for rotator cuff injuries. J Shoulder Elbow Surg. 2022; 31(12):e620-e627. DOI: 10.1016/j.jse.2022.06.021. View

4.
Junqueira D, Phillips R, Zorzela L, Golder S, Loke Y, Moher D . Time to improve the reporting of harms in randomized controlled trials. J Clin Epidemiol. 2021; 136:216-220. DOI: 10.1016/j.jclinepi.2021.04.020. View

5.
Hogan K, Fraga G . Compliance With Standards for STARD 2015 Reporting Recommendations in Pathology. Am J Clin Pathol. 2020; 154(6):828-836. DOI: 10.1093/ajcp/aqaa103. View